CRISPR Therapeutics
CRSP
#3176
Rank
$3.86 B
Marketcap
$45.37
Share price
0.00%
Change (1 day)
5.36%
Change (1 year)

Operating Margin for CRISPR Therapeutics (CRSP)

Operating Margin as of October 2024 (TTM): -42.98%

According to CRISPR Therapeutics's latest financial reports and stock price the company's current Operating Margin is -42.98%. At the end of 2023 the company had an Operating Margin of -40.74%.

Operating Margin history for CRISPR Therapeutics from 2016 to 2023

Operating Margin at the end of each year

Year Operating Margin Change
2023-40.74%-99.97%
2022-149,197.25%-359040.83%
202141.57%-100.06%
2020-64,098.71%-275890.36%
201923.24%-100.44%
2018-5,263.38%3139.59%
2017-162.47%-63.07%
2016-439.93%-95.79%
2015-10,453.85%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
0.00%N/A๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.